This trial studies how well treatment that is directed by genetic testing works against certain cancers that have gotten worse after at least one standard treatment, or for which no standard treatment exists. Genetic tests look at the unique genes of the tumor cells. Patients with certain genetic abnormalities may benefit more from treatment which targets their tumor's particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with cancer.
To enroll or if you have questions about participation